These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33802253)

  • 1. Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm.
    El Amrani A; Viñolas X; Arias MA; Bazan V; Valdovinos P; Alegret JM
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Amiodarone Pre-Treatment as a Facilitator of the Acute Success of Electrical Cardioversion in Persistent Atrial Fibrillation.
    Alegret JM; Viñolas X; Tajes H; Valdovinos P; Palomares R; Arias MA; Bazán V
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):89-94. PubMed ID: 32096001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.
    Crijns HJ; Weijs B; Fairley AM; Lewalter T; Maggioni AP; Martín A; Ponikowski P; Rosenqvist M; Sanders P; Scanavacca M; Bash LD; Chazelle F; Bernhardt A; Gitt AK; Lip GY; Le Heuzey JY
    Int J Cardiol; 2014 Apr; 172(3):588-94. PubMed ID: 24556445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis.
    Um KJ; McIntyre WF; Mendoza PA; Ibrahim O; Nguyen ST; Lin SH; Duceppe E; Rochwerg B; Healey JS; Koziarz A; Lengyel AP; Bhatnagar A; Amit G; Chu VA; Whitlock RP; Belley-Côté EP
    Europace; 2022 Oct; 24(10):1548-1559. PubMed ID: 35654763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation.
    Lankveld T; de Vos CB; Limantoro I; Zeemering S; Dudink E; Crijns HJ; Schotten U
    Heart Rhythm; 2016 May; 13(5):1020-1027. PubMed ID: 26776554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.
    Gwag HB; Chun KJ; Hwang JK; Park SJ; Kim JS; Park KM; On YK
    PLoS One; 2018; 13(5):e0197352. PubMed ID: 29787592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does antiarrhythmic drugs premedication improve electrical cardioversion success in persistent atrial fibrillation?
    Toso E; Iannaccone M; Caponi D; Rotondi F; Santoro A; Gallo C; Scaglione M; Gaita F
    J Electrocardiol; 2017; 50(3):294-300. PubMed ID: 28069273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study.
    Gitt AK; Smolka W; Michailov G; Bernhardt A; Pittrow D; Lewalter T
    Clin Res Cardiol; 2013 Oct; 102(10):713-23. PubMed ID: 23812041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation.
    Wang D; Zhang F; Wang A
    Cardiol Res Pract; 2016; 2016():4139596. PubMed ID: 27022500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of the left atrial volume index in cardioversion success and its relationship with recurrence in patients with non-valvular atrial fibrillation subjected to electrical cardioversion: a study on diagnostic accuracy.
    Akdemir B; Altekin RE; Küçük M; Yanikoğlu A; Karakaş MS; Aktaş A; Demir İ; Ermiş C
    Anadolu Kardiyol Derg; 2013 Feb; 13(1):18-25. PubMed ID: 23070632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
    Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P
    Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic predictors of sinus rhythm control by amiodarone and electrical cardioversion in patients undergoing percutaneous transluminal mitral valvuloplasty for rheumatic atrial fibrillation.
    Guo GB; Hang CL; Chang HW; Wu CJ; Fang CY; Chen CJ
    Circ J; 2007 Jul; 71(7):1115-9. PubMed ID: 17587720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion.
    Toufan M; Kazemi B; Molazadeh N
    J Cardiovasc Thorac Res; 2017; 9(1):54-59. PubMed ID: 28451089
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation.
    Son NKL; Park JW; Kim M; Yang SY; Yu HT; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    Korean Circ J; 2020 Jun; 50(6):511-523. PubMed ID: 32212425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
    Viñolas X; Freire F; Romero-Menor C; Alegret JM
    Med Clin (Barc); 2013 Apr; 140(8):351-5. PubMed ID: 22982132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.
    van Breugel HN; Gelsomino S; de Vos CB; Accord RE; Tieleman RG; Lucà F; Rostagno C; Renzulli A; Parise O; Lorusso R; Crijns HJ; Maessen JG
    Int J Cardiol; 2014 Aug; 175(2):290-6. PubMed ID: 24882697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
    Tveit A; Seljeflot I; Smith P; Arnesen H; Svendsen JH
    Immunobiology; 2013 Oct; 218(10):1256-60. PubMed ID: 23731775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.